tiprankstipranks
Trending News
More News >
Insperity Inc (NSP)
NYSE:NSP

Insperity (NSP) AI Stock Analysis

Compare
381 Followers

Top Page

NSP

Insperity

(NYSE:NSP)

Select Model
Select Model
Select Model
Neutral 43 (OpenAI - 5.2)
Rating:43Neutral
Price Target:
$21.50
â–¼(-6.28% Downside)
Action:ReiteratedDate:02/12/26
The score is held down primarily by weakened financial performance—especially the sharp deterioration in cash flow, margin compression, and high leverage versus equity. Technicals also remain bearish with the stock below key moving averages. Offsetting factors include constructive 2026 recovery guidance and a high dividend yield, but the very high P/E and execution risks (healthcare claims and modest WSE outlook) limit upside confidence.
Positive Factors
High client retention / sticky PEO base
Very high retention indicates a sticky client base and recurring revenue from PEO service fees. With retention near 99% monthly, churn risk is low, supporting predictable revenue and cross-sell opportunities. This durability underpins revenue stability and reduces customer acquisition dependence over the next several quarters.
Platform strategy (HRScale) progressing
HRScale is a structural investment to lower per‑employee service costs, broaden TAM and create subscription-like recurring revenue. Early beta rollouts and a multi-thousand WSE target imply potential secular margin and retention improvements as platform adoption scales, offering lasting operational leverage if execution continues.
Enhanced liquidity / credit flexibility
A larger, extended revolving facility materially improves financial flexibility, providing a multi-quarter runway to fund HRScale, weather claims volatility, and execute cost actions without immediate refinancing pressure. This reduces short-term liquidity risk and supports strategic execution while turnaround progresses.
Negative Factors
Severe cash flow weakness
A dramatic cash outflow shift is a durable concern: material negative operating and free cash flow strains working capital and funding. Even with adjusted earnings improving, sustained cash consumption increases reliance on credit, limits reinvestment capacity and raises the prospect of liquidity actions if cash trends don't reverse.
High leverage and thin equity cushion
A thinly capitalized balance sheet with high debt relative to equity reduces financial flexibility and increases covenant and refinancing risk. This limited equity cushion amplifies downside from further losses or adverse claims experience, potentially forcing asset sales, dilutive capital raises, or constrained strategic choices over the next several quarters.
Margin compression and profitability deterioration
Widening margin pressure—largely from elevated healthcare claims and benefit costs—erodes the core economics of the PEO model, which relies on benefits-related gross profit. Persistently compressed margins limit cash generation and make the business sensitive to claims cycles, meaning profit recovery must be sustained to restore financial health.

Insperity (NSP) vs. SPDR S&P 500 ETF (SPY)

Insperity Business Overview & Revenue Model

Company DescriptionInsperity, Inc. provides human resources (HR) and business solutions to improve business performance for small and medium-sized businesses. The company offers its HR services through its Workforce Optimization and Workforce Synchronization solutions that include a range of human resources functions, such as payroll and employment administration, employee benefits, workers' compensation, government compliance, performance management, and training and development services. It also provides Insperity Premier, a cloud-based human capital management platform that offers professional employer organization HR outsourcing solutions to its clients; personnel record management services; and employer liability management services, as well as solutions for middle market. In addition, the company offers MarketPlace, an e-commerce portal that offers a range of products and services; and Workforce Acceleration, a human capital management and payroll services solution; time and attendance; performance management; organizational planning; recruiting; employment screening; retirement; and insurance services. As of December 31, 2021, it operated through 85 sales offices in the United States. The company was formerly known as Administaff, Inc. and changed its name to Insperity, Inc. in March 2011. The company was founded in 1986 and is headquartered in Kingwood, Texas.
How the Company Makes MoneyInsperity generates revenue primarily through its Professional Employer Organization (PEO) services, where it acts as a co-employer for its clients. The company charges a fee based on a percentage of the client's payroll, which includes various services such as payroll processing, benefits administration, and compliance management. Additionally, Insperity earns revenue from its HR software solutions and consulting services, which can be offered on a subscription basis or as one-time fees. Key revenue streams include the fees from PEO services, HR software subscriptions, and consulting projects. Insperity's growth is also bolstered by strategic partnerships with various service providers in areas like insurance and employment services, allowing it to enhance its offerings and attract more clients.

Insperity Key Performance Indicators (KPIs)

Any
Any
Revenue by Geography
Revenue by Geography
Breaks down where Insperity earns sales across regions, highlighting geographic strengths and concentration risk. Regional trends reveal growth opportunities, exposure to local economic cycles or regulatory changes, and where the company’s sales and marketing efforts are most effective.
Chart InsightsInsperity’s revenue recovery is concentrated in the Northeast, but 2025 features a pronounced Q1 spike across regions followed by sequential softening — consistent with a seasonal or one‑time payroll/booking surge rather than durable demand acceleration. Management’s call flags a tepid hiring backdrop and only modest workforce growth, while pricing actions and a UnitedHealthcare agreement should stabilize revenue and blunt benefit-cost pressure; however, margin recovery and sustainable organic expansion remain uncertain given elevated health costs and hiring challenges.
Data provided by:The Fly

Insperity Earnings Call Summary

Earnings Call Date:Feb 10, 2026
(Q4-2025)
|
% Change Since: |
Next Earnings Date:May 05, 2026
Earnings Call Sentiment Neutral
The call balanced clear, concrete actions and a constructive outlook for 2026 (notably meaningful adjusted EBITDA and EPS recovery guidance, HRScale rollout progress, cost reductions and improved pricing) against significant near-term challenges (sharp 2025 profitability declines, elevated healthcare claims, lower starting paid worksite employee counts and some short-term sales impacts from margin actions). Management provided a detailed remediation plan and optimistic multi-year thesis centered on margin recovery and HRScale-driven future growth, but near-term risks and recent negative results temper enthusiasm.
Q4-2025 Updates
Positive Updates
2026 Profitability Guidance Shows Significant Improvement
Management forecasted full-year 2026 adjusted EBITDA of $170M to $230M (up ~30% to 76% vs. 2025) and adjusted EPS of $1.69 to $2.72 (up ~64% to 164% vs. 2025), indicating expectation of meaningful profitability recovery.
Q4 Results Near Forecast After Adjustments
Reported Q4 2025 adjusted EPS of -$0.60 and adjusted EBITDA of -$13M; excluding a $2.8M sales office consolidation expense, adjusted EPS was -$0.54 and adjusted EBITDA was -$11M — described as near the middle of management's forecast ranges.
Worksite Employee Growth and Strong Monthly Retention
Average paid worksite employees in Q4 2025 were 312,377, up 1.1% YoY. Worksite employees from new clients increased 6% YoY in Q4, and client retention averaged ~99% per month during Q4 (annual client retention referenced in the ~83% range).
Operating Expense Discipline and Fall Campaign Margin Recovery
Operating expenses decreased 6% vs. Q4 2024. Management executed a fall sales/retention campaign focused on margin recovery and reported early signs of improved pricing and client selection driving step-ups in gross profit drivers.
HRScale Strategic Investment and Launch Progress
Invested $59M in HRScale in 2025 (of which $48M expensed and $11M capitalized); Q4 investment was $15M ($10M expense, $5M capitalized). Beta clients scheduled to go live; management expects ~6,000–8,000 paid worksite employees on HRScale by year-end 2026, opening a larger TAM and future revenue/retention benefits.
Shareholder Returns and Improved Liquidity Profile
Returned capital via $90M in cash dividends for the year and repurchased 232,000 shares for $19M. Amended credit facility extended maturity to Dec 15, 2028, increased borrowing capacity from $650M to $750M, and left $380M of available capacity as of Dec 31, 2025.
Negative Updates
Material Profitability Declines in 2025
For the full year 2025 adjusted EBITDA declined 51% to $131M and adjusted EPS declined 71% to $1.03. Q4 2025 results were negative on both adjusted EPS (-$0.60) and adjusted EBITDA (-$13M), reflecting significant near-term profitability pressure.
Elevated Healthcare Claim Costs and Margin Pressure
An industry-wide step-up in health care claim costs materially squeezed gross profit margins; management expects elevated claims trends to continue into 2026. Pricing increases are expected to be 'in the teens' on average, and cost-side mitigations (UnitedHealthcare renegotiation and plan changes) were estimated to reduce costs by ~2%.
Lower Starting Headcount Reduces 2026 Growth Outlook
Year-end transition actions and weaker client net hiring led to several thousand fewer paid worksite employees than expected, reducing the starting point for 2026 and lowering projected growth by roughly 3%. Management's 2026 guidance for average paid worksite employees is a modest range of -1.5% to +1.5% vs. 2025; Q1 is guided to 303k–305k (a decline of 0.3% to 1% YoY).
Near-Term Sales Impact from Margin Recovery Actions
Margin recovery pricing and improved client selection contributed to lower-than-expected new booked sales in November and December, and some increase in company-initiated nonrenewals; these steps improved expected profitability but weighed on immediate growth.
Restructuring, Cash and Interest Headwinds
Company initiated a realignment affecting ~4% of non-sales staff and expects a $9M restructuring charge (excluded from adjusted measures). Adjusted cash was $57M at quarter-end, interest income is expected to be ~$7M lower in 2026, and management may draw on the credit facility if needed.
Company Guidance
The company provided detailed 2025 results and 2026 guidance: Q4 adjusted EPS was negative $0.60 (adjusted EPS excluding a $2.8M sales-office consolidation was negative $0.54) and Q4 adjusted EBITDA was negative $13M (minus $11M excl. consolidation); average paid worksite employees (WSE) in Q4 were 312,377 (up 1.1% YoY), WSE from new clients rose 6% YoY, and Q4 monthly client retention averaged 99%; gross profit per WSE was $183/month; Q4 operating expenses fell 6% YoY but included a $2.8M consolidation charge; Q4 HRScale investment was $15M ($10M op ex, $5M capitalized) versus $19M a year ago; dividends paid were $22M in Q4 and $90M for the year, and the company repurchased 232,000 shares for $19M, ending the quarter with $57M of adjusted cash; full-year 2025 average WSE was just over 310,000 (+1%), adjusted EBITDA was $131M (down 51%) and adjusted EPS was $1.03 (down 71%), with $59M invested in HRScale for the year ($48M expensed, $11M capitalized). For 2026 the company forecasts Q1 average WSE of 303,000–305,000 (down 0.3%–1% YoY) and full-year average WSE down 1.5% to up 1.5% (noting a ~3% headwind from a lower starting WSE), expects 6,000–8,000 paid WSE on HRScale by year-end, plans ~$20M of year-over-year operating expense savings (excluding a $9M restructuring charge) partly from eliminating ~4% of non‑sales headcount, expects HRScale-related operating expenses to be about $12M lower than 2025, anticipates CapEx of roughly $40M–$45M, a ~34% adjusted tax rate and ~$7M lower interest income, and is guiding full-year adjusted EBITDA of $170M–$230M (up 30%–76%) and adjusted EPS of $1.69–$2.72 (up 64%–164%), with Q1 adjusted EBITDA $81M–$111M and Q1 adjusted EPS $1.03–$1.50; the credit facility was amended to $750M capacity (available capacity $380M at 12/31/25) and maximum leverage was increased to 3.75x EBITDA.

Insperity Financial Statement Overview

Summary
Despite sharp 2025 revenue acceleration, profitability and cash generation deteriorated materially: net income and operating profit turned negative, margins compressed, leverage is high versus a thin equity base, and operating/free cash flow swung deeply negative—raising liquidity and funding risk if not reversed.
Income Statement
42
Neutral
Revenue accelerated sharply in 2025 (annual revenue growth of ~81%), but profitability deteriorated materially: net income turned slightly negative and operating profit moved to a small loss, with EBITDA margin compressing to ~0.3% versus ~3.0% in 2024. Gross margin also stepped down to ~13.2% from ~16.0% in 2024, indicating weaker unit economics and/or pricing pressure. Overall, strong top-line momentum is outweighed by the abrupt margin collapse and return to losses.
Balance Sheet
28
Negative
Leverage is high and worsening: debt stayed roughly flat (~$435M), while equity declined to ~$46M in 2025 (from ~$97M in 2024), pushing debt relative to equity to ~9.5x. Total assets also fell in 2025, and returns to shareholders turned negative alongside the net loss. The balance sheet is workable but thinly capitalized, leaving limited cushion if profitability and cash generation remain pressured.
Cash Flow
18
Very Negative
Cash generation weakened dramatically in 2025: operating cash flow swung to about -$278M (from +$520M in 2024) and free cash flow turned to about -$309M (from +$482M in 2024), with a steep negative free-cash-flow growth rate. Despite only a small net loss, the company consumed substantial cash, signaling unfavorable working-capital dynamics and/or elevated cash uses that materially raise liquidity and funding risk if sustained.
BreakdownDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue6.81B6.58B6.49B5.94B4.97B
Gross Profit900.00M1.05B1.04B1.01B820.10M
EBITDA35.00M198.00M295.00M300.29M214.32M
Net Income-7.00M91.00M171.00M179.35M124.08M
Balance Sheet
Total Assets2.20B2.60B2.12B2.04B1.75B
Cash, Cash Equivalents and Short-Term Investments660.00M1.05B709.00M765.90M607.60M
Total Debt435.00M435.00M427.00M424.99M433.59M
Total Liabilities2.16B2.50B2.03B1.96B1.75B
Stockholders Equity46.00M97.00M94.00M81.28M-1.77M
Cash Flow
Free Cash Flow-309.00M482.00M158.37M317.36M227.25M
Operating Cash Flow-278.00M520.00M198.49M347.69M260.15M
Investing Cash Flow-31.00M-38.00M-21.73M-32.12M-31.01M
Financing Cash Flow-90.00M-173.00M-155.01M-141.15M-208.07M

Insperity Technical Analysis

Technical Analysis Sentiment
Negative
Last Price22.94
Price Trends
50DMA
37.83
Negative
100DMA
38.54
Negative
200DMA
47.37
Negative
Market Momentum
MACD
-5.19
Positive
RSI
24.75
Positive
STOCH
19.21
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For NSP, the sentiment is Negative. The current price of 22.94 is below the 20-day moving average (MA) of 31.32, below the 50-day MA of 37.83, and below the 200-day MA of 47.37, indicating a bearish trend. The MACD of -5.19 indicates Positive momentum. The RSI at 24.75 is Positive, neither overbought nor oversold. The STOCH value of 19.21 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for NSP.

Insperity Risk Analysis

Insperity disclosed 22 risk factors in its most recent earnings report. Insperity reported the most risks in the "Legal & Regulatory" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Insperity Peers Comparison

Overall Rating
UnderperformOutperform
Sector (63)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
73
Outperform
$3.11B12.0813.89%2.89%3.65%5.71%
66
Neutral
$795.90M14.9124.08%0.88%9.64%9.93%
63
Neutral
$10.79B15.437.44%2.01%2.89%-14.66%
59
Neutral
$2.39B17.8010.02%8.65%-7.27%-43.88%
51
Neutral
$1.20B-89.53-0.64%4.96%-2.44%-156.01%
48
Neutral
$1.63B10.87111.30%1.81%0.99%-47.02%
43
Neutral
$834.93M-117.01-9.79%6.37%3.19%-86.21%
* Industrials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
NSP
Insperity
22.94
-61.19
-72.73%
BBSI
Barrett Business Services
26.83
-13.14
-32.87%
KFY
Korn Ferry
62.93
0.26
0.42%
MAN
ManpowerGroup
27.90
-25.60
-47.85%
RHI
Robert Half
24.75
-29.44
-54.33%
TNET
TriNet Group
37.71
-34.31
-47.64%

Insperity Corporate Events

Business Operations and StrategyFinancial Disclosures
Insperity Announces Realignment Plan and Workforce Reductions
Negative
Feb 10, 2026

On February 10, 2026, Insperity announced a Realignment Plan that will eliminate about 4% of its non-sales roles as part of an internal reorganization aimed at boosting efficiency and sharpening focus on key business areas, with an estimated $9 million in one-time severance and related charges largely recognized in the first quarter of 2026 and excluded from non-GAAP metrics. The company also reported a 2025 net loss of $7 million despite 4% revenue growth to $6.8 billion and modest WSEE gains, as elevated benefits costs pressured margins, prompting management to emphasize margin recovery, cost efficiencies and disciplined hiring, while returning $109 million to shareholders in 2025 and issuing 2026 guidance that points to a planned rebound in adjusted EBITDA and earnings.

The most recent analyst rating on (NSP) stock is a Hold with a $42.00 price target. To see the full list of analyst forecasts on Insperity stock, see the NSP Stock Forecast page.

Business Operations and StrategyPrivate Placements and Financing
Insperity Expands Credit Facility with Amegy Bank
Positive
Dec 16, 2025

On December 15, 2025, Insperity, Inc. announced an Eighth Amendment to its Amended and Restated Credit Agreement with Zions Bancorporation, N.A. dba Amegy Bank and other lenders. This amendment increases the borrowing capacity under its revolving credit facility from $650 million to $750 million, with a potential increase to $800 million, extends the maturity date to December 15, 2028, and adjusts financial covenants, potentially enhancing Insperity’s financial flexibility and operational capacity.

The most recent analyst rating on (NSP) stock is a Hold with a $36.00 price target. To see the full list of analyst forecasts on Insperity stock, see the NSP Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Feb 12, 2026